Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to conduct a Phase IIa human challenge trial evaluating ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...
The Punch on MSN
Demand surges for anti-HIV injection
Nigerians have begun scrambling for Lenacapavir, a newly introduced injection for the prevention of Human Immunodeficiency Virus, ahead of its nationwide rollout.Findings by Sunday PUNCH showed that ...
HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...
Health and Me on MSN
Rabies pre-exposure prophylaxis vaccine can protect you even before a dog bite—here’s how
Rabies is a deadly viral infection, mostly spread by dog bites. Here’s how the rabies pre-exposure prophylaxis vaccine works, who should get it, and why taking it before a bite can offer crucial ...
Nigeria has begun preparations to roll out Lenacapavir, a long-acting injectable HIV prevention drug, across eight states and ...
Elizabeth M. Stone ([email protected]), Rutgers University, New Brunswick, New Jersey. Nicholas J. Seewald, University of Pennsylvania, Philadelphia, Pennsylvania ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results